According to filings with the U.S. Securities and Exchange Commission, Biomakers is raising up to $7,999,999.00 in new funding. Sources indicate that as part of senior management President, Nicolas Kirchuk played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biomakers
Biomakers is a precision medicine innovation company which seeks to have an impact on extending the life span of millions of patients with advanced diseases in the world through genetic sequencing, in-depth bioinformatic analysis and the development of innovative technologies, allowing thousands of health professionals to make the best therapeutic decisions based on high-quality scientific data, and building cutting-edge platforms that enable the development of new and better personalized drugs. Biomakers has a team of scientific experts in molecular biology, molecular pathology and genetic and a great multi-platform capacity for the determination of molecular alterations with the highest quality standards at a global level.

To learn more about Biomakers, visit http://www.biomakers.net/

Contact:
Nicolas Kirchuk, President
617-401-6610
https://www.linkedin.com/in/nicolas-kirchuk-b7825339/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.